BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27451262)

  • 1. Current practice and access to prostate MR imaging in France.
    Renard-Penna R; Rouvière O; Puech P; Borgogno C; Abbas L; Roy C; Claudon M; Correas JM; Cormier L; Ploussard G; Mejean A; Tezenas-du-Montcel S; Rozet F
    Diagn Interv Imaging; 2016 Nov; 97(11):1125-1129. PubMed ID: 27451262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
    Muthigi A; Sidana A; George AK; Kongnyuy M; Maruf M; Valayil S; Wood BJ; Pinto PA
    Urol Oncol; 2017 Jan; 35(1):32.e1-32.e7. PubMed ID: 27743850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer.
    Costa DN; Lotan Y; Rofsky NM; Roehrborn C; Liu A; Hornberger B; Xi Y; Francis F; Pedrosa I
    J Urol; 2016 Jan; 195(1):80-7. PubMed ID: 26192254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
    Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
    Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
    Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer.
    Abdi H; Pourmalek F; Zargar H; Walshe T; Harris AC; Chang SD; Eddy C; So AI; Gleave ME; Machan L; Goldenberg SL; Black PC
    Urology; 2015 Feb; 85(2):423-8. PubMed ID: 25623709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of a cell-cycle progression score in men with prostate cancer managed with active surveillance after MRI-guided prostate biopsy--a pilot study.
    Arsov C; Jankowiak F; Hiester A; Rabenalt R; Quentin M; Schimmöller L; Blondin D; Antoch G; Albers P
    Anticancer Res; 2014 May; 34(5):2459-66. PubMed ID: 24778061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
    Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
    Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience.
    van de Ven WJ; Venderink W; Sedelaar JP; Veltman J; Barentsz JO; Fütterer JJ; Cornel EB; Huisman HJ
    Int Urol Nephrol; 2016 Jul; 48(7):1037-45. PubMed ID: 27068817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate MRI: a national survey of Urologist's attitudes and perceptions.
    Manley BJ; Brockman JA; Raup VT; Fowler KJ; Andriole GL
    Int Braz J Urol; 2016; 42(3):464-71. PubMed ID: 27286108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.